연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
3121. Multi-targeted therapy resistance via drug-induced secretome fucosylation
Mark Borris D Aldonza # 1 2 3 4 5, Junghwa Cha # 6, Insung Yong 6, Jayoung Ku 1, Pavel Sinitcyn 7, Dabin Lee 4 5, Ryeong-Eun Cho 1, Roben D Delos Reyes 8, Dongwook Kim 3 5, Soyeon Kim 9 10, Minjeong Kang 1, Yongsuk Ku 1, Geonho Park 1, Hye-Jin Sung 3 5, Han Suk Ryu 11, Sukki Cho 12, Tae Min Kim 9 10, Pilnam Kim # 6 13, Je-Yoel Cho # 3 4 5, Yoosik Kim # 1 13 14 15
Elife
. 2023 Mar 24:12:e75191.
Link
3120. Intrathoracic Progression is Still the Most Dominant Failure Pattern after First-line Chemo-immunotherapy in Extensive-stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy
Dowook Kim 1 2, Hak Jae Kim 2 3 4, Hong-Gyun Wu 2 3 4, Joo Ho Lee 2 4, Suzy Kim 2 5, Tae Min Kim 3 6, Jin-Soo Kim 7, Byoung Hyuck Kim 2 5
Cancer Res Treat
. 2023 Nov 6
Link
3119. Facial Cutaneous Rosai-Dorfman Disease: Dermoscopic Findings with Successful Surgical Treatment
Keunyoung Hur 1, Ji Yeon Hong 1, Kyu Han Kim 1, Jihui Jeon 2, Cheol Lee 3, Yoonjin Kwak 3, Tae Min Kim 4, Je-Ho Mun 5
Ann Dermatol
. 2023 Nov;35(Suppl 2):S287-S291
Link
3118. Deep learning based on dynamic susceptibility contrast MR imaging for prediction of local progression in adult-type diffuse glioma (grade 4)
Donggeon Heo # 1, Jisoo Lee # 1, Roh-Eul Yoo 2 3, Seung Hong Choi 4 5 6 7, Tae Min Kim 8, Chul-Kee Park 9, Sung-Hye Park 10, Jae-Kyung Won 10, Joo Ho Lee 11, Soon Tae Lee 12, Kyu Sung Choi 13, Ji Ye Lee 13, Inpyeong Hwang 13, Koung Mi Kang 13, Tae Jin Yun 13
Sci Rep
. 2023 Aug 24;13(1):13864.
Link
3117. A multicenter, phase II trial of GC1118, a novel anti-EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
Seung Won Choi 1, Hyun Ae Jung 2, Hee-Jin Cho 3, Tae Min Kim 4, Chul-Kee Park 5, Do-Hyun Nam 1, Se-Hoon Lee 2
Cancer Med
. 2023 Aug;12(15):15788-15796
Link
3116. Concomitant ruxolitinib with
cytarabine-based induction
chemotherapy in secondary acute
myeloid leukemia evolving from
myeloproliferative neoplasm
Dong Hyun Kim1, Ja Min Byun1,2, Dong-Yeop Shin1,2,3,4,
Inho Kim1,2,3,4, Sung-Soo Yoon1,2,3,4, Youngil Koh1,2,3,4
Blood Res
. 2023 Sep 30;58(3):155-157.
Link
3115. Prognostication of lung adenocarcinomas using CT-based deep learning of morphological and histopathological features: a retrospective dual-institutional study
Lee T, Lee KH, Lee JH, Park S, Kim YT, Goo JM, Kim H
Eur Radiol. 2023 Oct 20. Online ahead of print.
Link
3114. Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis
Lee JH, Choi Y, Hong H, Kim YT, Goo JM, Kim H
Eur Radiol. 2023 Aug 31. Online ahead of print.
Link
3113. Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas
Lim WH, Lee KH, Lee JH, Park H, Nam JG, Hwang EJ, Chung JH, Goo JM, Park S, Kim YT, Kim H
Eur Radiol. 2023 Sep 2. Online ahead of print.
Link
3112. Risk Factors of Anastomosis Stricture After Esophagectomy and the Impact of Anastomosis Technique
Na B, Kang CH, Na KJ, Park S, Park IK, Kim YT
Ann Thorac Surg. 2023 May;115(5):1257-1264
Link